Revise down 1Q26 OP estim
1Q26 review: in line with
VRN11, stronger clinical
1Q26 preview: likely beat
Military tensions surroun
1Q26 preview: likely meet
POSCO International is mo
Risks priced in, earnings
1Q26 sales estimated at W
1Q26 preview: meets conse